Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.
about
Considerations for observational research using large data sets in radiation oncologyAvailability and integration of palliative care at US cancer centersComparison of cases captured in the national cancer data base with those in population-based central cancer registries.Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data BaseAssociation between hospital imaging use and venous thromboembolism events rates based on clinical data.Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base.Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base.Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.Effect of hospital volume on processes of breast cancer care: A National Cancer Data Base study.Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancerBurden of illness in adult survivors of childhood cancers: findings from a population-based national sample.Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgeryLow rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic featuresAdequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer.Variation in hospital treatment patterns for metastatic colorectal cancer.Who does not receive treatment for cancer?Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma.Regional variation in quality of prostate cancer care.Prognostic impact and therapeutic implications of sentinel lymph node micro-metastases in early-stage breast cancer patients.Quality measurement in breast cancer.Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer.Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base.Limited Use of Adjuvant Therapy in Patients With Resected Gallbladder Cancer Despite a Strong Association With Survival.Glioblastoma multiforme (GBM) in the elderly: initial treatment strategy and overall survival.Early mortality and overall survival of acute myeloid leukemia based on facility type.Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy?Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States.The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.Surgical wait time: A new health indicator in women with endometrial cancer.Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database.Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.A Contemporary Analysis of Surgical Trends in the Treatment of Squamous Cell Carcinoma of the Oropharynx from 1998 to 2012: A Report from the National Cancer Database.Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Survival Analysis from the National Cancer Database.Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program.
P2860
Q24289442-5F86902B-617A-41D8-944F-6CE13B3C0C3FQ24613115-DED9DA2A-E9B8-48B3-8852-87F42917B75CQ30597272-2BAD6981-D146-4665-906E-8538C62656A5Q30692732-819C7471-7795-419F-A31F-7DB817AA0691Q30802068-6D0BEC37-5FC8-4668-AAB3-57C445223124Q30842217-7EA81A77-464F-49B5-B1AD-7B41A3F3F3A4Q30853611-3F96DDDB-A5A9-4AF6-AE7B-B62D7258928CQ30975765-54A90087-5737-4347-B1DC-7ADEF7B6889EQ31076178-7DEE4ECD-F098-49AC-BD84-160BA41EDB6FQ31110269-17894BB0-17A1-43AA-80D6-11D90EB4FA4EQ31143169-B4DD098A-44A4-4FF8-A3A3-3A217D68AC49Q33725640-75D795E5-BE3F-415E-B7A6-AD1FA27BBC54Q34035632-1E51F03B-211E-4F0A-82EA-94B4CB16FF26Q34172017-D07B1081-1C62-4C38-A72C-449BD834AFC5Q34778720-DA81D30B-E635-4630-A551-E3AD9BB9C82EQ35133471-48C3DD4C-AE18-4AD6-9EC4-BA2B84FCA0D0Q36075331-64F96B1C-C864-4E18-95C3-2769B4944BE2Q36117240-4B16F20E-8FDC-4BBE-AC64-A17FC8D9C014Q36534764-0837B642-25AF-4231-AB93-E4FA12101BB3Q37141507-675E5C82-2F3C-42CC-A6F1-788EF14731A6Q37692870-DF7EC650-268B-4311-93FE-81C9B4154D3DQ37863619-5C36D4D9-A56F-48F5-86F8-03E6B041A3CBQ38244057-9B1142A8-86DD-4569-830B-12DB60F6053EQ38678474-60BEA013-DB8F-42D5-9EDD-67ED8CC646E5Q38689138-4EC2F362-D364-49A0-9AF2-B7448C60ABF3Q38735122-4DD7FED4-8075-45AB-823A-E7208F4976C3Q38773618-DF8DD6DE-7E82-4C64-B339-00D3EDC58099Q38822583-5952972E-87D2-4D84-8336-1067F13F35EAQ38848598-08C10C24-640B-4D7D-8CD5-606B3DF99955Q38906569-694587F1-89FB-411A-BDDF-4761AFC74774Q38984147-A92E8ABC-7C8E-4E68-AF53-A527100E4073Q39000817-737F67FD-C85A-4F1F-A8BB-3C5D5B63CC13Q39352364-542D74B7-9369-4296-B9E5-73185CB2D698Q39698969-2EF3764F-1382-4F81-BC67-4F608839752CQ39831758-76B8A412-A4F3-47B1-B36D-D4AB457665C0Q40299540-22FB08B7-CE42-446C-9A19-69B2EBAA5ED2Q40957716-565AD3EC-AF78-49A4-A44C-98221578B99AQ41040684-BDBAF9DE-B1C7-4182-AAA6-EF757AE66FDFQ41608117-7CE7B587-E77D-4E71-A165-9959AFA18997Q43562477-43D7E346-E986-44EC-815B-ED6B909F6FDA
P2860
Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparison of commission on ca ...... the National Cancer Data Base.
@ast
Comparison of commission on ca ...... the National Cancer Data Base.
@en
type
label
Comparison of commission on ca ...... the National Cancer Data Base.
@ast
Comparison of commission on ca ...... the National Cancer Data Base.
@en
prefLabel
Comparison of commission on ca ...... the National Cancer Data Base.
@ast
Comparison of commission on ca ...... the National Cancer Data Base.
@en
P2093
P356
P1476
Comparison of commission on ca ...... the National Cancer Data Base.
@en
P2093
Andrew K Stewart
Clifford Y Ko
David J Bentrem
David P Winchester
Karl Y Bilimoria
P304
P356
10.1200/JCO.2008.21.7018
P407
P577
2009-07-27T00:00:00Z